AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ARS Pharmaceuticals, Inc. Director's Dealing 2020

Dec 4, 2020

32159_dirs_2020-12-03_2baa2298-2232-45ab-884c-9703bbbb7894.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Silverback Therapeutics, Inc. (SBTX)
CIK: 0001671858
Period of Report: 2020-12-03

Reporting Person: CAPPS VICKIE L (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	52053	Direct